Market potential Medtrack serves the life sciences sector with business intelligence for sales, licensing, and M&A activity, presenting opportunities to offer targeted data enrichment, competitive benchmarking, and license analytics services to ID partnerships and investment prospects.

Partner targeting Leverage Medtrack’s datasets to identify potential drug development partners, CMOs, and CROs, enabling outbound teams to tailor outreach with high-value collaboration and outsourcing opportunities.

Forecasting value Use Medtrack to build market models and sales forecasts for life science clients, creating upsell opportunities around analytics dashboards, scenario planning, and performance tracking products.

Valuation support Offer services focused on accurate valuations of products and technologies using Medtrack data, targeting investor relations teams and corporate development units seeking rigorous due diligence inputs.

SMB adjacency Although the vendor base includes startups and mid-size firms, there is room to expand into smaller biotech and niche life science firms by providing affordable, scalable BI tools and licensing options aligned with their growth needs.